Exact Mass: 482.2026
Exact Mass Matches: 482.2026
Found 255 metabolites which its exact mass value is equals to given mass value 482.2026
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Daphnetoxin
A daphnane-type orthoester diterpene with potential cholesterol-lowering activity, found exclusively in plants of the family Thymelaeaceae.
7-Hydroxystaurosporine
D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents
Sodium humate
It is used as a food additive .
Heteroclitin
Heteroclitin D is a lignin from Kadsura medicinal plants with anti-liqid peroxidation. Heteroclitin D inhibits L-type calcium channels[1]. Heteroclitin D is a lignin from Kadsura medicinal plants with anti-liqid peroxidation. Heteroclitin D inhibits L-type calcium channels[1].
heteroclitin D
Heteroclitin D is a lignin from Kadsura medicinal plants with anti-liqid peroxidation. Heteroclitin D inhibits L-type calcium channels[1]. Heteroclitin D is a lignin from Kadsura medicinal plants with anti-liqid peroxidation. Heteroclitin D inhibits L-type calcium channels[1].
1-{(7-hydroxy-5-methoxy-6-[18-(hydroxymethyl)oxiranyl]-16,18-dimethoxyphenoxy)phenyl}-2-(11-methoxyphenyl)ethane|isomoniliformine A
3,5-dimethoxy-4-(2R,3-dihydroxy-3-methylbutoxyl)-3,3-dimethylpyrano-(6,7)-isoflavone|pierreione A
4-demethyl bisorbibutenolide|demethylbisorbibutenolide
Tyr Thr Ala Glu
Ala Glu Thr Tyr
Ala Glu Tyr Thr
Ala Thr Glu Tyr
Ala Thr Tyr Glu
Ala Tyr Glu Thr
Ala Tyr Thr Glu
Asp Phe Thr Thr
Asp Ser Val Tyr
Asp Ser Tyr Val
Asp Thr Phe Thr
Asp Thr Thr Phe
Asp Val Ser Tyr
Asp Val Tyr Ser
Asp Tyr Ser Val
Asp Tyr Val Ser
Glu Ala Thr Tyr
Glu Ala Tyr Thr
Glu Phe Ser Thr
Glu Phe Thr Ser
Glu His Pro Thr
Glu His Thr Pro
Glu Pro His Thr
Glu Pro Thr His
Glu Ser Phe Thr
Glu Ser Thr Phe
Glu Thr Ala Tyr
Glu Thr Phe Ser
Glu Thr His Pro
Glu Thr Pro His
Glu Thr Ser Phe
Glu Thr Tyr Ala
Glu Tyr Ala Thr
Glu Tyr Thr Ala
Phe Asp Thr Thr
Phe Glu Ser Thr
Phe Glu Thr Ser
Phe Ser Glu Thr
Phe Ser Thr Glu
Phe Thr Asp Thr
Phe Thr Glu Ser
Phe Thr Ser Glu
Phe Thr Thr Asp
His Glu Pro Thr
His Glu Thr Pro
His Pro Glu Thr
His Pro Thr Glu
His Thr Glu Pro
His Thr Pro Glu
Pro Glu His Thr
Pro Glu Thr His
Pro His Glu Thr
Pro His Thr Glu
Pro Thr Glu His
Pro Thr His Glu
Ser Asp Val Tyr
Ser Asp Tyr Val
Ser Glu Phe Thr
Ser Glu Thr Phe
Ser Phe Glu Thr
Ser Phe Thr Glu
Ser Thr Glu Phe
Ser Thr Phe Glu
Ser Val Asp Tyr
Ser Val Tyr Asp
Ser Tyr Asp Val
Ser Tyr Val Asp
Thr Ala Glu Tyr
Thr Ala Tyr Glu
Thr Asp Phe Thr
Thr Asp Thr Phe
Thr Glu Ala Tyr
Thr Glu Phe Ser
Thr Glu His Pro
Thr Glu Pro His
Thr Glu Ser Phe
Thr Glu Tyr Ala
Thr Phe Asp Thr
Thr Phe Glu Ser
Thr Phe Ser Glu
Thr Phe Thr Asp
Thr His Glu Pro
Thr His Pro Glu
Thr Pro Glu His
Thr Pro His Glu
Thr Ser Glu Phe
Thr Ser Phe Glu
Thr Thr Asp Phe
Thr Thr Phe Asp
Thr Tyr Ala Glu
Thr Tyr Glu Ala
Val Asp Ser Tyr
Val Asp Tyr Ser
Val Ser Asp Tyr
Val Ser Tyr Asp
Val Tyr Asp Ser
Val Tyr Ser Asp
Tyr Ala Glu Thr
Tyr Ala Thr Glu
Tyr Asp Ser Val
Tyr Asp Val Ser
Tyr Glu Ala Thr
Tyr Glu Thr Ala
Tyr Ser Asp Val
Tyr Ser Val Asp
Tyr Thr Glu Ala
Tyr Val Asp Ser
Tyr Val Ser Asp
(r)-(-)-5,5,6,6,7,7,8,8-octahydro-3,3-di-t-butyl-1,1-bi-2-naphthol, dipotassium salt
Tilorone dihydrochloride
C78272 - Agent Affecting Nervous System > C47796 - Cholinergic Agonist D007155 - Immunologic Factors > D007369 - Interferon Inducers D000890 - Anti-Infective Agents > D000998 - Antiviral Agents D000893 - Anti-Inflammatory Agents D000970 - Antineoplastic Agents Tilorone dihydrochloride is an orally active interferon (IFN) inducer with broad-spectrum antiviral activities. Tilorone dihydrochloride possesses robust anti-Severe fever with thrombocytopenia syndrome virus (SFTSV) activity in vitro and in vivo through stimulation of host innate immunity. Tilorone dihydrochloride can penetrate the blood-brain barrier to activate HIF in the CNS[1][2][3].Tilorone dihydrochloride exhibits an inhibitory activity with EC50 of 230 nM against Ebola virus (EBOV)[4].
3-[[[2-[[(4-Cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]pyridin-2-ylamino]propionic acid ethyl ester
1,1,3,3,3,3-hexamethylindodicarbocyanine perchlorate
Pierreione A
A methoxyisoflavone that is isoflavone substituted by methoxy groups at positions 5 and 3, a 2R,3-dihydroxy-3-methylbutoxyl group at position 4 and a dimethylpyran ring fused across positions 6 and 7. Isolated from Antheroporum pierrei, it exhibits antineoplastic activity.
7-Hydroxystaurosporine
D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor D000970 - Antineoplastic Agents
2-[[3-butyl-6-(4-morpholinyl)-4-oxo-2-quinazolinyl]thio]-N-(3-methoxyphenyl)acetamide
Tert-butyl 2-[5-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethoxy]-4-oxo-2-phenylchromen-7-yl]oxyacetate
N-[1-(1H-benzimidazol-2-yl)-2-phenylethyl]-1-(2,3-dihydro-1,4-benzodioxin-6-yl)-5-oxo-3-pyrrolidinecarboxamide
(2S)-2-[[oxo-[5-[oxo-[(phenylmethyl)amino]methyl]-1H-imidazol-4-yl]methyl]amino]-3-phenylpropanoic acid (phenylmethyl) ester
N-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-2-[(1-ethyl-2-oxo-4-quinolinyl)oxy]acetamide
(2S)-2-[[[4-[(3-methylanilino)-oxomethyl]-1H-imidazol-5-yl]-oxomethyl]amino]-3-phenylpropanoic acid (phenylmethyl) ester
N-(4-chlorobenzyl)-2-((2R,3S,6S,Z)-3,4-dimethyl-5,12-dioxo-2-phenyl-1-oxa-4-azacyclododec-8-en-6-yl)acetamide
(2S,3S,3aR,9bR)-7-(cyclopenten-1-yl)-3-(hydroxymethyl)-2-(morpholine-4-carbonyl)-1-(1,3-thiazol-2-ylmethyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one
N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1,3-benzothiazole-2-carboxamide
N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1,3-benzothiazole-2-carboxamide
N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1,3-benzothiazole-2-carboxamide
N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1,3-benzothiazole-2-carboxamide
N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1,3-benzothiazole-2-carboxamide
N-[(5R,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1,3-benzothiazole-2-carboxamide
N-[(2S,3R)-4-[(2-chlorophenyl)methyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N,4-dimethylbenzenesulfonamide
N-[(2R,3R)-4-[(2-chlorophenyl)methyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N,4-dimethylbenzenesulfonamide
(2R,3R,3aS,9bS)-7-(cyclopenten-1-yl)-3-(hydroxymethyl)-2-(morpholine-4-carbonyl)-1-(1,3-thiazol-2-ylmethyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one
N-[(2R,3S)-4-[(2-chlorophenyl)methyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N,4-dimethylbenzenesulfonamide
N-[(2S,3S)-4-[(2-chlorophenyl)methyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N,4-dimethylbenzenesulfonamide
N-[(2S,3S)-4-[(2-chlorophenyl)methyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N,4-dimethylbenzenesulfonamide
(1R)-N-(2-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-1-(2-methoxy-1-oxoethyl)-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]carboxamide
(1S)-N-(2-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-1-(2-methoxy-1-oxoethyl)-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]carboxamide
N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1,3-benzothiazole-2-carboxamide
N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1,3-benzothiazole-2-carboxamide
N-[(2S,3R)-4-[(2-chlorophenyl)methyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N,4-dimethylbenzenesulfonamide
N-[(2R,3S)-4-[(2-chlorophenyl)methyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N,4-dimethylbenzenesulfonamide
N-[(2R,3R)-4-[(2-chlorophenyl)methyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N,4-dimethylbenzenesulfonamide
4-[(2R,5R)-3-hydroxy-5-[4-[[(2R)-2-hydroxy-2-(4-hydroxyphenyl)ethyl]amino]-4-oxobutanoyl]oxy-6-methyloxan-2-yl]oxypentanoate
4-[(2s,3s)-3-(hydroxymethyl)-5-methoxy-7-[2-(4-methoxyphenyl)ethyl]-2,3-dihydro-1,4-benzodioxin-2-yl]-2,6-dimethoxyphenol
8-(benzoyloxy)-4,9-dimethyl-14-methylidene-13-oxo-5,12-dioxatricyclo[9.3.0.0⁴,⁶]tetradec-9-en-2-yl 2,3-dimethyloxirane-2-carboxylate
(1s,12s,13r,14r)-18,19-dimethoxy-13,14-dimethyl-20-oxo-3,6,8-trioxapentacyclo[9.9.1.0¹,¹⁶.0⁴,²¹.0⁵,⁹]henicosa-4(21),5(9),10,16,18-pentaen-12-yl (2e)-2-methylbut-2-enoate
(1s,12r,13s,14s)-19,20-dimethoxy-13,14-dimethyl-18-oxo-3,6,8-trioxapentacyclo[9.9.1.0¹,¹⁶.0⁴,²¹.0⁵,⁹]henicosa-4(21),5(9),10,16,19-pentaen-12-yl (2e)-2-methylbut-2-enoate
(2s,3r,4r,6r)-4-[hydroxy(methyl)amino]-3-methoxy-2-methyl-29-oxa-1,7,17-triazaoctacyclo[12.12.2.1²,⁶.0⁷,²⁸.0⁸,¹³.0¹⁵,¹⁹.0²⁰,²⁷.0²¹,²⁶]nonacosa-8(13),9,11,14(28),15(19),16,20(27),21(26),22,24-decaen-16-ol
(5ar,7ar,11as,11bs)-7a,11b-dihydroxy-3-(4-hydroxy-3-methoxyphenyl)-5a,8,8,11a-tetramethyl-7,12-dihydro-6h-2,5-dioxatetraphene-1,11-dione
5-methoxy-6-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.1²,⁶.0⁷,²⁸.0⁸,¹³.0¹⁵,¹⁹.0²⁰,²⁷.0²¹,²⁶]nonacosa-8(13),9,11,14(28),15(19),17,20(27),21(26),22,24-decaene-9,18-diol
(12r,13s,14s)-18,19-dimethoxy-13,14-dimethyl-20-oxo-3,6,8-trioxapentacyclo[9.9.1.0¹,¹⁶.0⁴,²¹.0⁵,⁹]henicosa-4(21),5(9),10,16,18-pentaen-12-yl (2z)-2-methylbut-2-enoate
(11r,12s,13s)-3,22-dimethoxy-12,13-dimethyl-5,7,18,20-tetraoxapentacyclo[13.7.0.0²,¹⁰.0⁴,⁸.0¹⁷,²¹]docosa-1(15),2,4(8),9,16,21-hexaen-11-yl (2z)-2-methylbut-2-enoate
(2s,3r,4r,6r,18r)-3-methoxy-2-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.1²,⁶.0⁷,²⁸.0⁸,¹³.0¹⁵,¹⁹.0²⁰,²⁷.0²¹,²⁶]nonacosa-8(13),9,11,14(28),15(19),16,20(27),21(26),22,24-decaene-16,18-diol
(2s,3s,4s,5s,6r)-5-methoxy-6-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.1²,⁶.0⁷,²⁸.0⁸,¹³.0¹⁵,¹⁹.0²⁰,²⁷.0²¹,²⁶]nonacosa-8(13),9,11,14(28),15(19),17,20(27),21(26),22,24-decaene-3,18-diol
n-[(2s,3r,4r,6r)-3-hydroxy-6-{12-hydroxy-3,13,23-triazahexacyclo[14.7.0.0²,¹⁰.0⁴,⁹.0¹¹,¹⁵.0¹⁷,²²]tricosa-1(16),2(10),4(9),5,7,11(15),12,17(22),18,20-decaen-3-yl}-2-methyloxan-4-yl]ethanimidic acid
4-[3-(hydroxymethyl)-5-methoxy-7-[2-(4-methoxyphenyl)ethyl]-2,3-dihydro-1,4-benzodioxin-2-yl]-2,6-dimethoxyphenol
angeloylgomisin r
{"Ingredient_id": "HBIN016116","Ingredient_name": "angeloylgomisin r","Alias": "NA","Ingredient_formula": "C27H30O8","Ingredient_Smile": "CC=C(C)C(=O)OC1C(C(CC2=CC3=C(C(=C2C4=C(C5=C(C=C14)OCO5)OC)OC)OCO3)C)C","Ingredient_weight": "482.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1210","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "44593602","DrugBank_id": "NA"}